Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CSL prepares novel humanized IL-3R-alpha-directed antibodies

March 23, 2012

First-in-human trial of H1N1 influenza vaccine using iBioLaunch technology completed

March 23, 2012

Novel naphthoquinones designed in China

March 23, 2012

Line extension for Taxol approved in Japan

March 22, 2012

Chroma Therapeutics designs new histone deacetylase inhibitors

March 22, 2012

Merck & Co. presents new potential cancer therapies

March 22, 2012

GSK gives update on FDA's ODAC review of Votrient

March 21, 2012

FDA's ODAC votes regarding approval of ridaforolimus

March 21, 2012

Taiho and Nordic Group launch Teysuno

March 21, 2012

Companies seek approval in Japan for biosimilar of filgrastim

March 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...